RPT-China markets feel the pain of stalled derivatives rollout

SHANGHAI/HONG KONG, Nov 4 (Reuters) – A long list of stock and currency derivatives has been lying in wait for regulatory approval at the China Financial Futures Exchange (CFFEX), some for nearly a decade. “You need to tell the public that not every fund manager coming to China is George Soros, that you use derivatives to manage long positions, not to short China,” the exchange’s vice president Zhang Xiaogang told a seminar in Shanghai. Zhang told his audience of mostly China-based executives of global money managers to speak up for the benefits of derivatives in investments, as “bad public perception makes it difficult for new products to be approved”.